Chemomab Therapeutics (CMMB) Stock Price, Quote, News & History

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL2...

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Benzinga

Benzinga

Chemomab Therapeutics Ltd (CMMB) Stock Price, Quote, News & History

Key Statistics

Recent Chemomab Therapeutics Ltd News

Chemomab Therapeutics' Touts Positive Data From Experimental Drug For Chronic Liver Disease

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise

Financials

Cash Flows

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Compare

FAQ

How do I buy Chemomab Therapeutics (CMMB) stock?

Who are Chemomab Therapeutics (CMMB) competitors?

What is the forecast, or price target, for Chemomab Therapeutics (CMMB) stock?

What is the current price for Chemomab Therapeutics (CMMB)?

Does Chemomab Therapeutics (CMMB) pay a dividend?

When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?

Is Chemomab Therapeutics (CMMB) going to split?

What sector and industry does Chemomab Therapeutics (CMMB) operate in?

People Also Watch

Key Statistics

Recent Chemomab Therapeutics Ltd News

Chemomab Therapeutics' Touts Positive Data From Experimental Drug For Chronic Liver Disease

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise

Financials

Cash Flows

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Bulls vs Bears

Compare

FAQ

How do I buy Chemomab Therapeutics (CMMB) stock?

Who are Chemomab Therapeutics (CMMB) competitors?

What is the forecast, or price target, for Chemomab Therapeutics (CMMB) stock?

What is the current price for Chemomab Therapeutics (CMMB)?

Does Chemomab Therapeutics (CMMB) pay a dividend?

When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?

Is Chemomab Therapeutics (CMMB) going to split?

What sector and industry does Chemomab Therapeutics (CMMB) operate in?

People Also Watch

Bulls vs Bears